Change in HER2 status after neoadjuvant chemotherapy and the prognostic impact in patients with primary breast cancer

E-ISSN： 1096-9098|116|8|1021-1028

ISSN： 0022-4790

Source： JOURNAL OF SURGICAL ONCOLOGY, Vol.116, Iss.8, 2017-12, pp. : 1021-1028

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of neoadjuvant chemotherapy on pathologic axillary nodal status in HER‐2 positive patients presenting with clinically node‐negative disease

JOURNAL OF SURGICAL ONCOLOGY, Vol. 112, Iss. 5, 2015-12 ,pp. : 453-457

John Wiley & Sons Inc

Access to resources Recommend Favorite

Targeted Intraoperative Radiotherapy Tumour Bed Boost During Breast Conserving Surgery after Neoadjuvant Chemotherapy in HER2 Positive and Triple Negative Breast Cancer

Reviews on Recent Clinical Trials, Vol. 12, Iss. 2, 2017-05 ,pp. : 93-100

Bentham Science Publishers

Access to resources Recommend Favorite

Neoadjuvant Therapy for HER2-positive Breast Cancer

Reviews on Recent Clinical Trials, Vol. 12, Iss. 2, 2017-05 ,pp. : 81-92

Bentham Science Publishers

Access to resources Recommend Favorite

T-DM1 in the Neo-Adjuvant Treatment of HER2-Positive Breast Cancer: Impact of the KRISTINE (TRIO-021) Trial

Reviews on Recent Clinical Trials, Vol. 12, Iss. 3, 2017-11 ,pp. : 216-222

Bentham Science Publishers

Access to resources Recommend Favorite

Impact of neoadjuvant chemotherapy on axillary nodal involvement in patients with clinically node negative triple negative breast cancer

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 2, 2015-02 ,pp. : 198-202

John Wiley & Sons Inc

Access to resources Recommend Favorite